Published in

Taylor and Francis Group, OncoImmunology, 6(8), p. e1588084, 2019

DOI: 10.1080/2162402x.2019.1588084

Links

Tools

Export citation

Search in Google Scholar

Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival

Journal article published in 2019 by Abdulla Watad ORCID, Dennis McGonagle ORCID, Nicola L. Bragazzi ORCID, Shmuel Tiosano ORCID, Doron Comaneshter, Yehuda Shoenfeld ORCID, Arnon D. Cohen ORCID, Howard Amital ORCID
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO